A randomized trial of iloperidone for prevention of relapse in schizophrenia: the REPRIEVE study
PJ Weiden, R Manning, CD Wolfgang, JM Ryan… - CNS drugs, 2016 - Springer
… haloperidol 12.5 mg (52-week relapse estimate by Kaplan–Meier [KM] method was 43.5 %
… The primary endpoint was a comparison of the time until first relapse event between groups. …
… The primary endpoint was a comparison of the time until first relapse event between groups. …
… in first episode of psychosis: PAFIP 3-year follow-up randomized clinical trials comparing haloperidol, olanzapine, risperidone, aripiprazole, quetiapine, and …
M Gómez-Revuelta, JM Pelayo-Terán… - International Journal …, 2020 - academic.oup.com
… may be a key point to optimize treatment in patients suffering a first episode of psychosis to
… is to compare the clinical effectiveness of olanzapine, risperidone, haloperidol, aripiprazole, …
… is to compare the clinical effectiveness of olanzapine, risperidone, haloperidol, aripiprazole, …
Oral and long‐acting antipsychotics for relapse prevention in schizophrenia‐spectrum disorders: a network meta‐analysis of 92 randomized trials including 22,645 …
G Ostuzzi, F Bertolini, F Tedeschi, G Vita… - World …, 2022 - Wiley Online Library
… of extrapyramidal symptoms; haloperidol-OS, haloperidol-LAI … 3-monthly, risperidone-LAI,
risperidone-OS and paliperidone-… in preventing relapse and re-hospitalization as compared to …
risperidone-OS and paliperidone-… in preventing relapse and re-hospitalization as compared to …
Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial
… Midazolam use was significantly lower among those in the placebo arm compared with the
risperidone and haloperidol arms combined on each study day (13 of 75 [17.3%] vs 50 of 144 …
risperidone and haloperidol arms combined on each study day (13 of 75 [17.3%] vs 50 of 144 …
Examination of dosing of antipsychotic drugs for relapse prevention in patients with stable schizophrenia: a meta-analysis
… compared fixed doses of a second-generation antipsychotic, haloperidol, or fluphenazine for
relapse prevention … 5-mg/d risperidone equivalent may provide limited additional benefit for …
relapse prevention … 5-mg/d risperidone equivalent may provide limited additional benefit for …
Better evidence for pharmacological maintenance treatment in nonaffective psychoses: implications for relapse prevention
WG Honer - American Journal of Psychiatry, 2021 - Am Psychiatric Assoc
… in preventing relapse (risk difference… (haloperidol used in 10 of 11 studies, risk
difference=−0.11, 95% CI=−0.15 to −0.07) (11). A meta-analysis of randomized controlled trials …
difference=−0.11, 95% CI=−0.15 to −0.07) (11). A meta-analysis of randomized controlled trials …
Time to discontinuation of second-generation antipsychotics versus haloperidol and sulpiride in people with schizophrenia: a naturalistic, comparative study
HY Chan, YJ Pan, JJ Chen… - Journal of clinical …, 2017 - journals.lww.com
… of Cox regression revealed similar results, with the only exception of risperidone, which
demonstrated a significantly longer time to discontinuation compared with haloperidol (Table 5). …
demonstrated a significantly longer time to discontinuation compared with haloperidol (Table 5). …
Haloperidol versus second‐generation antipsychotics in the long‐term treatment of schizophrenia
M Buoli, RS Kahn, M Serati… - Human …, 2016 - Wiley Online Library
… than those treated with risperidone. In the current analysis, risperidone is the compound …
This study supports a major effectiveness of atypical antipsychotics compared to haloperidol in …
This study supports a major effectiveness of atypical antipsychotics compared to haloperidol in …
Comparison of relapse prevention with 3 different paliperidone formulations in patients with schizophrenia continuing versus discontinuing active antipsychotic …
M Mathews, S Gopal, A Singh, I Nuamah… - Neuropsychiatric …, 2020 - Taylor & Francis
… the three studies to compare the time-to-relapse and related change in efficacy scales, in
patients suddenly discontinuing antipsychotics (patients randomized to placebo groups) vs …
patients suddenly discontinuing antipsychotics (patients randomized to placebo groups) vs …
Optimal doses of specific antipsychotics for relapse prevention in a nationwide cohort of patients with schizophrenia
… , olanzapine, and quetiapine were associated with higher risk of relapse whereas no
difference was found for low dose risperidone compared with standard dose of the same drug. A …
difference was found for low dose risperidone compared with standard dose of the same drug. A …